These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2192234)

  • 21. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis.
    Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L
    J Neurosci Res; 2001 Nov; 66(3):517-24. PubMed ID: 11746371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries.
    Cortese I; Tafi R; Grimaldi LM; Martino G; Nicosia A; Cortese R
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11063-7. PubMed ID: 8855309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dendritic cells and their role in inflammation in the central nervous system].
    Pashchenkov MV; Pinegin BV; Link Kh; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):39-46. PubMed ID: 12938633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to cerebellar soluble lectin CSL in multiple sclerosis.
    Zanetta JP; Warter JM; Kuchler S; Marschal P; Rumbach L; Lehmann S; Tranchant C; Reeber A; Vincendon G
    Lancet; 1990 Jun; 335(8704):1482-4. PubMed ID: 1972431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.
    Bhise V; Dhib-Jalbut S
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1069-89. PubMed ID: 27191526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [IgG synthesis in the central nervous system in multiple sclerosis and other neurologic diseases. Measurement and validity].
    Safár J; Vymazal J; Tichý J; Růzicková V
    Cas Lek Cesk; 1985 Sep; 124(36):1131-6. PubMed ID: 4028102
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1986 Jul; 20(1):20-5. PubMed ID: 2427010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current trends in autoimmunity and the nervous system.
    Selmi C; Barin JG; Rose NR
    J Autoimmun; 2016 Dec; 75():20-29. PubMed ID: 27545842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spleen versus CNS immunoglobulin G in multiple sclerosis: an isoelectric focusing study.
    Mavra M; Newcombe J; Keir G; Thompson EJ
    Acta Neurol Scand; 1990 Feb; 81(2):125-7. PubMed ID: 2109479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis.
    Schrijver IA; van Meurs M; Melief MJ; Wim Ang C; Buljevac D; Ravid R; Hazenberg MP; Laman JD
    Brain; 2001 Aug; 124(Pt 8):1544-54. PubMed ID: 11459746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulins within the central nervous system in primary Sjögren's syndrome.
    Vrethem M; Ernerudh J; Lindström F; Skogh T
    J Neurol Sci; 1990 Dec; 100(1-2):186-92. PubMed ID: 1708408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response.
    Jacobi C; Lange P; Reiber H
    J Neuroimmunol; 2007 Jul; 187(1-2):139-46. PubMed ID: 17512988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immune studies in multiple sclerosis.
    Bar-Or A
    Adv Neurol; 2006; 98():91-109. PubMed ID: 16400829
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].
    Hommes OR
    Ned Tijdschr Geneeskd; 1976 Mar; 120(10):424-30. PubMed ID: 765862
    [No Abstract]   [Full Text] [Related]  

  • 37. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-GFAP antibodies in the cerebrospinal fluid of patients with multiple sclerosis and other neurologic diseases].
    Górny M; Losy J; Wender M
    Neurol Neurochir Pol; 1990; 24(1-2):17-22. PubMed ID: 2132049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?
    Laffitte E; Burkhard PR; Fontao L; Jaunin F; Saurat JH; Chofflon M; Borradori L
    Br J Dermatol; 2005 Mar; 152(3):537-40. PubMed ID: 15787824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.